ferric citrate (AURYXIA) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Ferric citrate or iron(III) citrate describes any of several complexes formed upon binding any of the several conjugate bases derived from citric acid with ferric ions. Most of these complexes are orange or red-brown. They contain two or more Fe(III) centers.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Alternative names

1,2,3-propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt (1:1) | 2-hydroxy-1,2,3-propanetricarboxylic acid iron salt | ferric citrate | ferric citrate, 59fe-labeled cpd | ferric citrate anhydrous | ferric citrate coordination complex | ferric citrate dihydrate | ferric citrate hydrate | ferric citrate iron(+3) salt | ferric citrate, iron salt, 59fe-labeled cpd | ferric citrate monohydrate | ferric citrate trihydrate | ferric-citric acid | ferrum citricum | fexeric | iron(iii) citrate | iron(iii) citrate tribasic | jtt-751 | krx-0502 | zerenex

Organizations (31)

Research & Development (31)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (15)

Approved Indications (5)


 

Anemia

Chronic Kidney Disease-Mineral and Bone Disorder (approved 2014)

Hyperphosphatemia

Iron Deficiencies (approved 2017)

Renal Insufficiency, Chronic

Experimental Indications - Clinical Trial Phases 1-4 (14)


 

Anemia, Iron-Deficiency (Phase 4)

Cardiovascular Diseases (Phase 3)

Chronic Kidney Disease-Mineral and Bone Disorder (Phase 3)

Disease Progression (Phase 3)

Healthy Volunteers (Phase 1)

Hyperphosphatemia (Phase 4)

Inflammation (Phase 4)

Iron (Phase 3)

Iron Deficiencies (Phase 3)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 4)

Phosphorus Metabolism Disorders (Phase 4)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 24
  • # of Trial Organizations: 31

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue